| Style | Citing Format |
|---|---|
| MLA | Asadollahzade E, et al.. "Comment on “Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis – a Longitudinal Observational Study”." Revista da Associacao Medica Brasileira, vol. 68, no. 12, 2022, pp. 1621-1622. |
| APA | Asadollahzade E, Ghadiri F, Ebadi Z, Moghadasi AN (2022). Comment on “Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis – a Longitudinal Observational Study”. Revista da Associacao Medica Brasileira, 68(12), 1621-1622. |
| Chicago | Asadollahzade E, Ghadiri F, Ebadi Z, Moghadasi AN. "Comment on “Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis – a Longitudinal Observational Study”." Revista da Associacao Medica Brasileira 68, no. 12 (2022): 1621-1622. |
| Harvard | Asadollahzade E et al. (2022) 'Comment on “Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis – a Longitudinal Observational Study”', Revista da Associacao Medica Brasileira, 68(12), pp. 1621-1622. |
| Vancouver | Asadollahzade E, Ghadiri F, Ebadi Z, Moghadasi AN. Comment on “Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis – a Longitudinal Observational Study”. Revista da Associacao Medica Brasileira. 2022;68(12):1621-1622. |
| BibTex | @article{ author = {Asadollahzade E and Ghadiri F and Ebadi Z and Moghadasi AN}, title = {Comment on “Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis – a Longitudinal Observational Study”}, journal = {Revista da Associacao Medica Brasileira}, volume = {68}, number = {12}, pages = {1621-1622}, year = {2022} } |
| RIS | TY - JOUR AU - Asadollahzade E AU - Ghadiri F AU - Ebadi Z AU - Moghadasi AN TI - Comment on “Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis – a Longitudinal Observational Study” JO - Revista da Associacao Medica Brasileira VL - 68 IS - 12 SP - 1621 EP - 1622 PY - 2022 ER - |